Livforsakringsbolaget Skandia Omsesidigt Purchases Shares of 15,900 Option Care Health, Inc. $OPCH

Key Points

• Livforsakringsbolaget Skandia Omsesidigt invested approximately $516,000 in Option Care Health, purchasing 15,900 shares during the second quarter.
• Analyst reports have upgraded Option Care Health with target prices as high as $38.00, reflecting a consensus rating of "Moderate Buy".
• The company reported a quarterly revenue of $1.42 billion, surpassing analyst expectations and showing a year-over-year revenue growth of 15.4%.

Livforsakringsbolaget Skandia Omsesidigt bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 15,900 shares of the company's stock, valued at approximately $516,000.

Several other institutional investors have also bought and sold shares of the stock. Public Employees Retirement System of Ohio lifted its holdings in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares in the last quarter. US Bancorp DE lifted its holdings in Option Care Health by 5.0% during the 1st quarter. US Bancorp DE now owns 8,199 shares of the company's stock worth $287,000 after purchasing an additional 393 shares in the last quarter. State of Michigan Retirement System lifted its holdings in Option Care Health by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock worth $1,425,000 after purchasing an additional 500 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in shares of Option Care Health by 1.1% in the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock valued at $1,667,000 after acquiring an additional 500 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its holdings in shares of Option Care Health by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock valued at $696,000 after acquiring an additional 525 shares in the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Stock Up 1.4%

Shares of OPCH stock traded up $0.38 during mid-day trading on Thursday, hitting $28.41. The company's stock had a trading volume of 1,614,166 shares, compared to its average volume of 1,705,882. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The business has a 50-day moving average price of $28.87 and a 200 day moving average price of $31.29. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a market cap of $4.61 billion, a price-to-earnings ratio of 22.73, a PEG ratio of 1.71 and a beta of 0.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. During the same quarter in the previous year, the business earned $0.30 earnings per share. The company's revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Timothy P. Sullivan acquired 20,000 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The stock was bought at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the acquisition, the director directly owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Norman L. Wright acquired 3,411 shares of the business's stock in a transaction that occurred on Tuesday, September 9th. The stock was purchased at an average cost of $29.31 per share, with a total value of $99,976.41. Following the acquisition, the director directly owned 15,501 shares of the company's stock, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 59,411 shares of company stock valued at $1,627,576 over the last 90 days. Company insiders own 0.64% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on OPCH shares. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities increased their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Finally, Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.